Jan Aushadhi Kendras Expand to 18646 Boost Affordable Medicines Access Explained

India has taken a major step toward improving affordable healthcare access with the rapid expansion of Jan Aushadhi Kendras under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. As of February 2026, the number of operational centres has reached 18,646, significantly strengthening the availability of low-cost generic medicines across the country.

The expansion of Jan Aushadhi Kendras is a crucial development in India’s healthcare ecosystem, especially at a time when rising medical costs continue to burden households. These centres provide medicines at prices that are substantially lower than branded alternatives, helping reduce out-of-pocket expenditure for millions of citizens. The latest update highlights the government’s continued focus on making quality healthcare affordable and accessible, particularly for low- and middle-income populations. With increasing public acceptance and strong sales growth, the initiative is emerging as a cornerstone of India’s healthcare affordability strategy.

Jan Aushadhi Kendras Reach 18,646 Mark Nationwide

The Government of India has significantly expanded its network of Jan Aushadhi Kendras, with 18,646 centres now operational across the country as of February 2026. The development marks a major milestone in the implementation of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), which aims to provide quality generic medicines at affordable prices.

Union Minister of State for Chemicals and Fertilisers Anupriya Patel emphasized that these centres are playing a vital role in bridging the gap between healthcare needs and affordability. By offering medicines at prices that are typically 50 to 80 percent lower than branded drugs, the scheme is helping millions of Indians access essential treatments without financial strain.

The initiative is implemented by the Pharmaceuticals & Medical Devices Bureau of India (PMBI), which is responsible for procurement, quality assurance, and distribution of medicines across the network.

Evolution of the Jan Aushadhi Scheme

The Jan Aushadhi initiative was launched with the objective of promoting generic medicines and reducing healthcare costs. Over the years, the scheme has evolved into one of the largest government-led healthcare affordability programs in India.

Initially, the number of centres was limited, and awareness among the public was relatively low. However, consistent policy support, awareness campaigns, and improved supply chains have contributed to rapid expansion.

In recent years, the government has accelerated the rollout of new centres, ensuring coverage in both urban and rural areas. This has significantly improved access to affordable medicines, particularly in underserved regions.

Government Measures Strengthen Affordable Healthcare Ecosystem

The expansion of Jan Aushadhi Kendras is part of a broader strategy to make healthcare more affordable and accessible. The government has introduced several complementary measures to regulate drug prices and ensure availability.

One of the key mechanisms is the Drugs Prices Control Order (DPCO), 2013, which regulates the pricing of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) monitors drug prices and ensures that pharmaceutical companies do not charge excessive rates.

Additionally, schemes such as the Free Drugs Service Initiative under the National Health Mission and the AMRIT (Affordable Medicines and Reliable Implants for Treatment) program provide subsidized medicines through public healthcare facilities.

These initiatives collectively aim to reduce the financial burden of healthcare on individuals and improve access to essential medicines.

Expert Insights and Healthcare Data

Healthcare experts have highlighted the importance of promoting generic medicines as a cost-effective solution to rising healthcare expenses.

According to a report by the World Health Organization generic medicines play a critical role in improving access to treatment, particularly in low- and middle-income countries.

Data released by the Ministry of Chemicals and Fertilizers shows that the Jan Aushadhi scheme has recorded total sales of over Rs. 4,728 crore in the last three financial years, indicating strong public acceptance and growing demand.

Experts at the National Health Systems Resource Centre have noted that increasing awareness and trust in generic medicines is essential for the long-term success of such initiatives.

The government has also intensified awareness campaigns to educate citizens about the quality and efficacy of generic drugs, addressing common misconceptions.

Impact on Economy and Public Health

The expansion of Jan Aushadhi Kendras is expected to have a significant impact on both the economy and public health outcomes in India. By reducing the cost of medicines, the scheme helps households save on healthcare expenses, freeing up income for other essential needs.

For the healthcare system, improved access to affordable medicines can lead to better treatment adherence and improved health outcomes. Patients are more likely to complete prescribed treatments when medicines are affordable and easily accessible.

From an economic perspective, the initiative supports the domestic pharmaceutical industry by promoting the production and consumption of generic drugs. This aligns with India’s position as a global leader in generic medicine manufacturing.

The scheme also contributes to reducing inequalities in healthcare access, particularly in rural and economically disadvantaged areas.

Future Outlook and Policy Direction

Looking ahead, the government is expected to further expand the network of Jan Aushadhi Kendras, with a focus on reaching remote and underserved regions. Strengthening supply chain infrastructure and ensuring consistent availability of medicines will be key priorities.

There is also a growing emphasis on integrating digital technologies to improve inventory management and distribution efficiency. Digital platforms could enable real-time tracking of medicine availability and enhance transparency.

As noted by the World Bank improving access to affordable healthcare is essential for achieving sustainable development goals and enhancing overall quality of life.

The continued success of the Jan Aushadhi scheme will depend on sustained policy support, effective implementation, and increased public awareness. If these factors are maintained, the initiative has the potential to transform India’s healthcare landscape and set an example for other countries.